The AIDS Pandemic: Impact on Science and SocietyKenneth H. Mayer, H.F. Pizer The AIDS Pandemic explores the ways in which HIV/AIDS has, and continues to transform the wide range of related disciplines it touches. Novel perspectives are provided by a unique panel of internationally recognised experts who cover the unprecedented impact onf AIDS on culture, demographics and politics around the world, including how it affected the worlds' economy, health sciences, epidemiology and public health. This important far- reaching analysis uses the lessons learned from a wide array of disciplines to help us understand the current status and evolution of the pandemic, as it continues to evolve. * Unique and timely presentation of new theories and perspectives* Concentrates on the changes that have taken place in a broad array of related disciplines* Provides key contextual information, for those new to the field or at interface areas between disciplines* Includes an international focus on evolving African and Asian experiences* Focuses on the current strategies for developing vaccines and microbicides* Outlines harm reduction and prevention programs* Explores issues related to delivery of life-saving AIDS medications in resource-constrained environments |
Contents
| 1 | |
| 13 | |
| 36 | |
3 Quantitative Science | 58 |
What Have We Learned? | 90 |
5 AIDS and Sexually Transmitted Disease Prevention and Control | 110 |
Antiretroviral Therapy as Prophylaxis | 137 |
7 Challenges in Developing HIV Vaccines | 162 |
Implications for Patient Care | 286 |
12 Economics | 307 |
The Challenges of Prices and Patents | 324 |
14 The African Experience | 351 |
Health Meets Human Rights | 374 |
And What Others Can Learn from Our Experience | 398 |
17 Drug Use | 424 |
18 Management of HIVAIDS in Correctional Settings | 449 |
Other editions - View all
The AIDS Pandemic: Impact on Science and Society Kenneth H. Mayer,Hank Pizer No preview available - 2005 |
Common terms and phrases
active AIDS epidemic AIDS medicines antibodies antiretroviral drugs antiretroviral therapy ARVs Asia associated blood buprenorphine cells cent challenges clinical trials condom cost developing countries effective efficacy efforts Engl evaluation follow-up funding genital global groups HAART harm reduction hepatitis HIV epidemic HIV infection HIV prevention HIV testing HIV transmission HIV vaccine HIV/AIDS human immunodeficiency virus IDUs Immune Defic Syndr immune responses impact increased individuals infectious diseases initial injection drug users inmates interventions JAMA Lancet lymphocytes methadone microbicides million National opportunistic infections organizations partners patients pharmaceutical population prevalence prisoners programs protection public health rates reduce regimens reported risk behavior San Francisco sex workers sexually transmitted diseases social South Africa STD control strategies subtype syphilis syringes tion transmission of HIV treatment tuberculosis UNAIDS vaginal viral load women zidovudine
Popular passages
Page 32 - Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV- 1 infection.
Page 30 - Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.
Page 35 - F. (1988). Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
Page 31 - RF, 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.